首页> 外文期刊>Jornal Vascular Brasileiro >Comparison of initial loading doses of 5 mg and 10 mg for warfarin therapy
【24h】

Comparison of initial loading doses of 5 mg and 10 mg for warfarin therapy

机译:华法林治疗的初始负荷剂量5 mg和10 mg的比较

获取原文
       

摘要

CONTEXT: The question of what is the best loading dosage of warfarin when starting anticoagulant treatment has been under discussion for ten years. We were unable to find any comparative studies of these characteristics conducted here in Brazil.OBJECTIVE: To compare the safety and efficacy of two initial warfarin dosage regimens for anticoagulant treatment.METHODS: One-hundred and ten consecutive patients of both sexes, with indications for anticoagulation because of venous or arterial thromboembolism, were analyzed prospectively. During the first 3 days of treatment, these patients were given adequate heparin to keep aPTT (activated partial thromboplastin time) between 1.5 and 2.5, plus 5 mg of warfarin. From the fourth day onwards, their warfarin doses were adjusted using International Normalized Ratios (INR; target range: 2 to 3). This prospective cohort was compared with a historical series of 110 patients had been given 10 mg of warfarin on the first 2 days and 5 mg on the third day with adjustments based on INR thereafter. Outcomes analyzed were as follows: recurrence of thromboembolism, bleeding events and time taken to enter the therapeutic range.RESULTS: Efficacy, safety and length of hospital stay were similar in both samples. The sample that were given 10 mg entered the therapeutic range earlier (means: 4.5 days vs. 5.8 days), were on lower doses at discharge and had better therapeutic indicators at the first return appointment.CONCLUSIONS: The 10 mg dosage regimen took less time to attain the therapeutic range and was associated with lower warfarin doses at discharge and better INR at first out-patients follow-up visit.
机译:上下文:开始抗凝治疗时,华法林的最佳负荷剂量是什么已经讨论了十年。我们在巴西找不到这些特征的比较研究。目的:比较两种华法林初始抗凝治疗方案的安全性和有效性。方法:一百零零个连续的男女患者,有适应症对因静脉或动脉血栓栓塞引起的抗凝治疗进行了前瞻性分析。在治疗的前三天,为这些患者提供足够的肝素,以使aPTT(活化的部分凝血活酶时间)维持在1.5至2.5之间,外加5毫克华法林。从第四天起,使用国际标准化比率(INR;目标范围:2到3)调整他们的华法林剂量。将该前瞻性队列与历史系列患者进行比较,对110例患者在前2天给予华法林10毫克,在第三天给予5毫克华法林,之后根据INR进行调整。分析的结果如下:血栓栓塞的复发,出血事件和进入治疗范围所需的时间。结果:两个样本的疗效,安全性和住院时间相似。给予10 mg的样品较早进入治疗范围(平均:4.5天vs. 5.8天),出院时剂量较低,首次回诊时具有较好的治疗指标。结论:10 mg剂量方案花费的时间更少达到治疗范围,并与出院时降低华法林剂量和首次门诊随访时INR升高有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号